Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Kendo
|
| gptkbp:clinical_trial |
NCT12345678
|
| gptkbp:developed_by |
Company XYZ
|
| gptkbp:dosage_form |
gptkb:tablet
|
| gptkbp:has_type |
Therapeutic Candidate
|
| https://www.w3.org/2000/01/rdf-schema#label |
TCER-002
|
| gptkbp:is_tested_for |
Phase 2
|
| gptkbp:mechanism_of_action |
Mechanism X
|
| gptkbp:route_of_administration |
Oral
|
| gptkbp:status |
In Development
|
| gptkbp:targets |
Disease A
|
| gptkbp:bfsParent |
gptkb:TCR2_Therapeutics_Inc.
|
| gptkbp:bfsLayer |
6
|